Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment

類似資料

• GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
  著者:: Alkhouri, Naim, 等
  出版事項: (2019)
• Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
  著者:: Alkhouri, Naim, 等
  出版事項: (2018)
• Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
  著者:: Alkhouri, Naim, 等
  出版事項: (2018)
• Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis
  著者:: Zimmer, Vincent, 等
  出版事項: (2016)
• Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes
  著者:: Alkhouri, Naim, 等
  出版事項: (2018)